Loading...
Search
AI Chat
AI Strategies
Products
Markets
News
Resources
Pricing
Home
Stock
CMOPF
CMOPF News & Events
-
Add to Watchlist
Trade CMOPF
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Forecast
Technical
Valuation
Financials
Earnings
News
CMOPF News
Cosmo Reports Significant Phase III Topline Results for Clascoterone 5% Solution in Male Hair Loss, Demonstrating Up to 539% Improvement in Hair Count Compared to Placebo; Submissions in the US and EU Are in Progress
Dec 03 2025
Yahoo Finance
Cosmo's Stock Soars Following Successful Male Hair Loss Treatment Trial Results
Dec 03 2025
SeekingAlpha
S&P Global Upgrades Cosmo's ESG Rating; Enhances Supplier Sustainability Oversight and Italian Manufacturing Facility Receives EcoVadis Bronze Medal
Nov 11 2025
Yahoo Finance
Cosmo Pharmaceuticals Receives Regulatory Green Light for Winlevi(R) in South Korea
Oct 07 2025
Yahoo Finance
Cosmo Secures Favorable CHMP Recommendation for Winlevi(R) as Acne Treatment for Adults and Teens After Successful Re-Evaluation
Aug 27 2025
Yahoo Finance
Cosmo and Takeda Renew Strategic Manufacturing Agreement for Global Supply of Oral Treatment for Ulcerative Colitis
Aug 08 2025
Yahoo Finance
Cosmo Delivers Strong Performance in H1 2025, Raises Full-Year EBITDA Guidance and Accelerates Recurring Revenue Growth Across AI and Dermatology
Jul 23 2025
Yahoo Finance
Cosmo Accelerates Global ESG Leadership with Major Ratings Upgrades, UN Compact Commitment, and Climate Action Pledge
Jul 16 2025
Yahoo Finance
Show More News
CMOPF Events
No data
CMOPF Monitor News
No data
CMOPF Earnings Analysis
No Data
People Also Watch
